Chapters
Transcript
Sara Tolaney, MD, MPH discusses updated standardized definitions for efficacy endpoints in adjuvant breast cancer clinical trials: STEEP Version 2.0.
Related Presenters
View full profile
Related Videos
Study of SACI-IO for Triple Negative Metastatic Breast Cancer
Trial 20-153: SACI-IO for Hormone Receptor Positive Metastatic Breast Cancer
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account